These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 29342127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Co-instillation of nano-solid magnesium hydroxide enhances corneal permeability of dissolved timolol.
    Nagai N, Ogata F, Otake H, Kawasaki N, Nakazawa Y, Kanai K, Okamoto N, Shimomura Y.
    Exp Eye Res; 2017 Dec; 165():118-124. PubMed ID: 28987318
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
    Trinquand C, Romanet JP, Nordmann JP, Allaire C, Groupe d'étude.
    J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Improvement of the ocular bioavailability of carteolol by ion pair.
    Higashiyama M, Tajika T, Inada K, Ohtori A.
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):333-9. PubMed ID: 17076627
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.
    Ohtori R, Sato H, Fukuda S, Ueda T, Koide R, Kanda Y, Kiuchi Y, Oguchi K.
    Exp Eye Res; 1998 Apr; 66(4):487-94. PubMed ID: 9593641
    [Abstract] [Full Text] [Related]

  • 12. [Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
    Schnarr KD.
    Klin Monbl Augenheilkd; 1988 Feb; 192(2):167-72. PubMed ID: 2896266
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Environmentally responsive ophthalmic gel formulation of carteolol hydrochloride.
    El-Kamel A, Al-Dosari H, Al-Jenoobi F.
    Drug Deliv; 2006 Feb; 13(1):55-9. PubMed ID: 16401594
    [Abstract] [Full Text] [Related]

  • 15. Ocular drug delivery using 20-kHz ultrasound.
    Zderic V, Vaezy S, Martin RW, Clark JI.
    Ultrasound Med Biol; 2002 Jun; 28(6):823-9. PubMed ID: 12113795
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Formulation of carteolol chitosomes for ocular delivery: formulation optimization, ex-vivo permeation, and ocular toxicity examination.
    Zafar A, Alruwaili NK, Imam SS, Alsaidan OA, Alharbi KS, Yasir M, Elmowafy M, Ansari MJ, Salahuddin M, Alshehri S.
    Cutan Ocul Toxicol; 2021 Dec; 40(4):338-349. PubMed ID: 34340615
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.